Heterologous and homologous COVID-19 mRNA vaccination schemes for induction of basic immunity show similar immunogenicity regarding long-term spike-specific cellular immunity in healthcare workers.

Publication date: Jul 20, 2024

Healthcare workers (HCWs) are recommended to receive at least three spike-antigen exposures to generate basic immunity and to mediate herd protection of vulnerable patients. So far, less attention has been put on the cellular immune response induced by homologous (three BTN162b2mRNA doses) or heterologous (mRNA-1273 as third dose building on two BTN162bmRNA doses) and the immunological impact of breakthrough infections (BTIs). Therefore, in 356 vaccinated HCWs with or without BTIs the Anti-SARS-CoV-2-Spike-IgG concentrations and avidities and B- and T-cell-reactivity against SARS-CoV-2-Spike-S1- and Nucleocapsid-antigens were assessed with Interferon-gamma-ELISpot and by flow-cytometry. HCWs who had hybrid immunity due to BTIs exhibited strong T-cell-reactivity against the Spike-S1-antigen. A lasso regression model revealed a significant reduction in T-cell immune responses among smokers (p

Open Access PDF

Concepts Keywords
Antigen Anti-SARS-CoV-2-Spike IgG
Btn162b2mrna COVID-19 vaccination
Covid Healthcare workers
Healthcare T-cellular immunity
Herd T-SPOT.COVID

Semantics

Type Source Name
disease MESH COVID-19
disease VO vaccination
disease VO dose
disease MESH breakthrough infections
disease VO vaccinated
disease IDO cell

Original Article

(Visited 4 times, 1 visits today)